This article is more than 5 years old. Information may no longer be current.
Vision business helps increase Johnson & Johnson’s quarterly results
Click Here to Manage Email Alerts
Johnson & Johnson announced sales of $20.8 billion in the second quarter of 2018, an increase of 10.6% from 2017’s second quarter totals, according to a company press release.
Net earnings for the quarter were $4 billion, or $1.45 per diluted share, which included an after-tax intangible amortization expense of about $1 billion, as well as a charge for after-tax special items of $0.8 billion, the release said.
Adjusted net earnings for the quarter, excluding the amortization expense and special items, were $5.7 billion, or $2.10 per share.
The company’s vision business, which includes Acuvue contact lenses and surgical products, helped drive its worldwide operational results, the release said.
Worldwide medical device sales were up 3.7% for the quarter to $7 billion with an operational increase of 1.9%. Domestic sales increased 1.1% and international sales were up by 6%.
Worldwide pharmaceutical sales increased 19.9% to $10.4 billion in the quarter, with an operational increase of 17.6%.